Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by theinvestor22on Sep 09, 2021 9:59am
141 Views
Post# 33830636

RE:RE:RE:RE:RE:Remote Cardiac Monitoring tech

RE:RE:RE:RE:RE:Remote Cardiac Monitoring techYou raise a good issue here.  Since the $11M sales includes monitor sales, it's the $2M/mth run rate that's more important.  Run rates are more important anyway, as they are closer to underlying figures than 1 year historical numbers are.  This is not news, Lisa already made the point that analysts are more interested in run rate numbers.

ryang999 wrote: These are all legit concerns. However they reiterated 2mm monthly run rate exiting December 2021. The hardware sales will be included in their 11mm revenue projection for CY 2021. Sure it will be much conforming if they can just be more forthcoming and release the number of patients onboarded


<< Previous
Bullboard Posts
Next >>